Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients

Table 1 Patient cohorts characteristics, subdivided by fibrosis stage

Fibrosis stage^a	F0	F1	F2	F3	F4	All stages
Age ^b
Mean age SD	43.75 ± 12.11	44.83 ± 12.64	51.24 ± 12.04	57.10 ± 10.49	57.33 ± 11.31	49.30 ± 13.08
Gender ^c
Women	52	85	66	36	28	267
Men	45	91	69	31	39	275
Number of patients	97	176	135	67	67	542
HCV genotype ^c
1	70	126	100	50	43	390
2	2	12	1	1	3	19
3	11	25	12	5	7	60
4	0	4	4	1	0	9
Other	0	1	0	0	0	1
NA	14	8	18	10	14	64

^aHepatic fibrosis was assessed by examination of liver biopsies by an experienced pathologist and staged according to Desmet-Scheuer scoring system
^bFor the age, the mean value per fibrosis stage is reported along with the corresponding standard deviation
^cFor gender and HCV genotype absolute frequencies are given

ISSN: 1479-5876